A case of medullary thyroid carcinoma in which the skin metastasis was concurrently present and response occurred to chemotherapy

Medullary thyroid carcinoma accounts for 3% of all thyroid gland malignancies. It commonly metastasizes to liver, lung, and bone. It rarely metastasizes to skin, and only a few such cases have been documented. Cutaneous metastasis suggests a poor prognosis, with a mean survival of 7.5-19 months. The...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research and treatment 2008, 40(4), , pp.202-206
Main Authors: Choi, Won Je, Lee, Yun Young, Kim, Soyon, Kim, Yun Kwon, Kim, Eun Sil, Seo, Seung O, Jo, Jae Hyun, Lee, Seung Min, Lee, Hyo Jin
Format: Article
Language:English
Subjects:
Case Report
의약학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Medullary thyroid carcinoma accounts for 3% of all thyroid gland malignancies. It commonly metastasizes to liver, lung, and bone. It rarely metastasizes to skin, and only a few such cases have been documented. Cutaneous metastasis suggests a poor prognosis, with a mean survival of 7.5-19 months. The most effective treatment for skin metastasis is complete surgical removal of all local and regional lesions. The response to systemic chemotherapy is typically poor. We report a case of medullary thyroid carcinoma with cutaneous metastases, which responded to chemotherapy.
ISSN:1598-2998
2005-9256
DOI:10.4143/crt.2008.40.4.202